Nuvation Bio Inc (NUVB) — Financial Flexibility Index
Nuvation Bio Inc (NUVB) has a Financial Flexibility Index of 0.02x as of March 2026. Free cash flow of $5.12 Million (operating CF $5.07 Million minus capex $48.00K) represents 0% of total liabilities ($290.68 Million). Check asset allocation strategy of Nuvation Bio Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nuvation Bio Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Nuvation Bio Inc across 8 annual periods. See NUVB working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nuvation Bio Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Nuvation Bio Inc. For the full company profile including market capitalisation, see Nuvation Bio Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.60x | $-173.07 Million | $-173.43 Million | $289.11 Million | ▲ +64.7% |
| 2024 | -1.70x | $-130.25 Million | $-130.41 Million | $76.84 Million | ▲ +59.2% |
| 2023 | -4.15x | $-67.93 Million | $-68.00 Million | $16.36 Million | ▲ +26.0% |
| 2022 | -5.61x | $-95.74 Million | $-96.11 Million | $17.07 Million | ▼ -149.1% |
| 2021 | -2.25x | $-67.91 Million | $-68.19 Million | $30.15 Million | ▲ +58.5% |
| 2020 | -5.42x | $-36.38 Million | $-36.53 Million | $6.71 Million | ▲ +26.9% |
| 2019 | -7.42x | $-23.77 Million | $-24.43 Million | $3.20 Million | ▼ -15664.3% |
| 2018 | 0.05x | $43.00K | $-616.00K | $902.00K | — |